Healthcare Fabry Disease Treatment Market Haga clic para leer
  • Comentarios

Healthcare

Fabry Disease Treatment Market

Publicado el en “Salud y Estado Físico, Salud y Estado Físico”, Idioma — English. 8 páginas.
Fabry disease also called as Anderson-Fabry disease and alpha-galactosidase-A deficiency is an X-linked, hereditary, lysosomal storage disease caused due to paucity of an enzyme α galactosidase A (an enzyme required to metabolize lipids, fat-like substances that include oils, waxes, and fatty acids). The mutated gene leads the formation of lipids to harmful levels in various part of body such as the autonomic nervous system, cardiovascular system, eyes, and kidneys. Some of the common symptoms o Más
Mostrar Etiquetas

Otras publicaciones de “Healthcare”

Ver todas las publicaciones